GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
HALOZYME THERAPEUTIC (HALO) [hlAlert]

Rating:
Sell HALO
down 50.11 %

HALOZYME THERAPEUTIC (HALO) rated Sell

Posted on: Tuesday,  Sep 11, 2007  9:25 AM ET by Morgan Joseph

Morgan Joseph rated Sell HALOZYME THERAPEUTIC (NASDAQ: HALO) on 09/11/2007, when the stock price was $9.00. Since
then, HALOZYME THERAPEUTIC has gained 100.44% as of 08/27/2015's recent price of $18.04.
If you would have followed this Morgan Joseph's recommendation on HALO, you would have lost 50.11% of your investment in 2907 days.

Halozyme Therapeutics, Inc. (Halozyme) is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix (Matrix) for the endocrinology, oncology, dermatology and drug delivery markets The Company's products are based on the property covering the family of human enzymes known as hyaluronidases. The Company has two marketed products: HYLENEX, a product used as an adjuvant to increase the absorption and dispersion of other injected drugs and fluids, and Cumulase, a product used for in vitro fertilization (IVF). The Company has partnerships with F. Hoffmann-La Roche, Ltd and Hoffmann-La Roche, Inc. (Roche), to apply Enhanze Technology to Roche?s biological therapeutic compounds for up to 13 targets, and with Baxter Healthcare Corporation (Baxter), to apply Enhanze Technology to Baxter?s biological therapeutic compound, GAMMAGARD LIQUID.

Morgan Joseph is committed to providing timely, objective and actionable investment advice on the companies and securities we follow. Our team of equity analysts covers a growing universe of stock issues across a broad range of industry sectors. As a middle market-focused firm, our approach is not to publish research on as many companies as possible within a number of industry sectors. Rather, our research analysts distinguish themselves by zeroing in on quality companies with growth prospects or which present special situations. These companies often lack a research following. This enables our analysts to provide insight to investors in companies that are not well understood nor fairly valued.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/11/2007 9:25 AM Sell
None
9.00 6.00
as of 8/27/2015
1 Week up  14.58 %
1 Month up  17.32 %
3 Months down  -10.60 %
1 YTD down  -20.34 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy